News

September 20, 2019September 20, 2019

Owlstone Launches New Generation of Tools to Support ID of Disease Biomarkers on Person’s Breath

News

Owlstone Medical announced that it has introduced a new ReCIVA Breath Sampler and CASPER Portable Air Supply, designed to support researchers working to identify disease biomarkers and to measure levels ... Read more

September 18, 2019September 18, 2019

FDA Grants ‘Humanitarian Use Device’ Status to Tool for PAH Biopsies, Supporting Possible Approval

News

The Endoarterial Biopsy Catheter (EABC), a tool for performing biopsies on lung artery walls to better evaluate pulmonary arterial hypertension (PAH) in people and responses to treatment, has been ... Read more

September 16, 2019September 18, 2019

Acceleron’s Sotatercept Receives FDA’s Orphan Drug Status for PAH

News

The U.S. Food and Drug Administration (FDA) has granted orphan drug status to sotatercept for the treatment of pulmonary arterial hypertension (PAH), according to Acceleron Pharma, the therapy’s manufacturer. ... Read more

September 13, 2019September 13, 2019

FDA Agrees to Review Trevyent, with PumpPatch System, as PAH Treatment

News, PAH News

The U.S. Food and Drug Administration (FDA) has agreed to review a request to approve Trevyent (treprostinil) as a treatment of pulmonary arterial hypertension (PAH), United Therapeutics announced in a press release. An ... Read more

September 12, 2019September 12, 2019

Israeli Group Pushes for Better Awareness and Treatment of Pulmonary Hypertension

News

For two-and-a-half painful years, Jerome Maharaj, 42, had no idea what was wrong with him. Born in South Africa, he came to Israel in 1996 and settled in Ma’agan, ... Read more

September 11, 2019September 11, 2019

FDA Grants Breakthrough Device Status to SoniVie’s TIVUS System for PAH

News

The U.S. Food and Drug Administration (FDA) has granted the designation of breakthrough device to SoniVie’s Therapeutic Intra-Vascular Ultrasound (TIVUS) System for the treatment of people with pulmonary arterial ... Read more

September 9, 2019September 11, 2019

Two Non-Invasive Tests Predict PAH Prognosis in Patients with Congenital Heart Disease, Study Reveals

News, PAH News

Only two non-invasive diagnostic tests are required to best predict the risk of adverse events in people with congenital heart disease (CHD)-associated pulmonary arterial hypertension (PAH), a new study ... Read more

September 6, 2019September 6, 2019

Swedish Men and Women with IPAH Have Similar Survival Rates, Study Says

News, PAH News

Swedish men and women who have been diagnosed with idiopathic pulmonary arterial hypertension (IPAH) in recent years have similar survival rates, study says. The study, “Sex-specific differences and survival in ... Read more

September 5, 2019September 5, 2019

Blocking Inflammatory Signaling in Specific Pulmonary Artery Cells Might Treat PAH, Study Says

News, PAH News

Targeting the pro-inflammatory TGF-β signaling pathway in specific cells of the pulmonary arteries — those with high levels of a protein called periostin — shows promise in treating pulmonary ... Read more

September 4, 2019September 4, 2019

BioNews’ PH Forum Fosters Community and Raises Awareness

News

Online forums have markedly altered how patients, caregivers, and healthcare professionals communicate and connect. Even when miles apart, people can establish supportive relationships, share experiences and information, and sometimes ... Read more

Pin It on Pinterest